EquipNet to Discuss Asset Management Systems at Interphex 2014
News Mar 14, 2014
Experts from EquipNet Inc. will be on hand at Interphex 2014 (18-20 March in New York City) to demonstrate and discuss the company’s unique asset management solution.
The industry-leading company is dedicated to the pharmaceutical, biotechnology and chemical markets; helping businesses redeploy or sell idle or surplus analytical instruments, process pilot, laboratory, and packaging equipment.
Asset management has evolved in recent years, with surveys showing companies have, on average, 5% of their assets lying idle. EquipNet has been at the forefront of these changes and now offers its clients a range of workflow and management solutions to aid redeployment or sale of business assets.
Their web-based system, ARMS™ (Asset Redeployment Management System) sits behind a company’s firewall, efficiently tracking and facilitating internally redeployment of equipment that is not being used in its current location.
Where an asset can not be relocated, it can be moved through into one of several sales channels. In every case, EquipNet specialists provide expert knowledge and proven project management skills to deliver a complete service package.
Ben Potenza, VP Marketing at EquipNet, said, “Working with both multinational enterprises as well as small and medium sized companies with a single facility, we provide our clients with options to redeploy or sell surplus plant and equipment to gain a real return on their investment.”
To find out more about EquipNet’s asset management expertise and how pharmaceutical industry companies have benefited, visit EquipNet on Booth #1239.
U.S. Study of Dapivirine Ring in Lactating Women Finds Little Drug Gets Into Breast MilkNews
The antiretroviral drug dapivirine that is released from an experimental vaginal ring to protect against HIV is absorbed in very low concentrations into breastmilk.READ MORE
Agilent Technologies Presents Thought Leader Award to Dr. Ram SasisekharanNews
Agilent Technologies awards Dr. Ram Sasisekharan with the Agilent Thought Leader Award in recognition of his contributions in the field of biologics characterization.READ MORE
CRISPR Reveals New Targets for Promising Cancer DrugsNews
Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.READ MORE
Comments | 0 ADD COMMENT
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018
EMBL Course: Target Engagement in Biology and Drug Discovery
Feb 19 - Feb 23, 2018
18th International Conference and Exhibition on Analytical & Bioanalytical Chromatographic Techniques
Nov 02 - Nov 03, 2017